This presentation was given by Professor Kara Hanson at the BMC Health Services Research Conference, in July 2014.
The presentation illustrates the important role that strategic purchasing can play in achieving effective health coverage, and how the topic is being studied by researchers. It highlights RESYST's multi-country study of purchasing arrangements that is currently taking place in Nigeria, Kenya, Tanzania, South Africa, India, Thailand and Vietnam.
The purpose of this presentation is to equip audiences with the ability to:
Define universal health coverage (UHC) and understand the basic tenets of UHC
Identify how UHC fits in USAID’s health and poverty reduction strategies
Effectively communicate to country stakeholders how USAID can support a country’s progress towards UHC
Identify relevant UHC resources within the Office of Health Systems and USAID
The presentation is part of the “UHC Toolkit” and accompanies Universal Health Coverage: An Annotated Bibliography, and Universal Health Coverage: Frequently Asked Questions.
Health Financing for UHC – two sides of the coinHFG Project
Presented at “Financial Protection and Improved Access to Health Care: Peer-to-Peer Learning Workshop Finding Solutions to Common Challenges” in Accra, Ghana, February 2016. To learn more, visit: https://www.hfgproject.org/ghana-uhc-workshop
Each year, the OHE sponsors a lecture that explores a timely issue in medicine or health economics. At the 22nd Annual Lecture, the issues and challenges of universal health care coverage in low- and middle-income countries were presented by Professor Anne Mills of the London School of Hygiene and Tropical Medicine.
The audio of this lecture now is available at http://news.ohe.org/2014/08/19/annual-lecture-2014-universal-health-coverage/
Universal Health Coverage (UHC) Day 12.12.14, NepalDeepak Karki
This presentation is made on the first ever Universal Health Coverage (UHC) Day 12.12.14 celebration in Nepal by Nepal Health Economics Association (NHEA).
Universal health coverage was established in the WHO constitution of 1948 declaring health a fundamental human right.The goal of universal health coverage is to ensure that all people obtain the health services they need without suffering financial hardship when paying for them.
The purpose of this presentation is to equip audiences with the ability to:
Define universal health coverage (UHC) and understand the basic tenets of UHC
Identify how UHC fits in USAID’s health and poverty reduction strategies
Effectively communicate to country stakeholders how USAID can support a country’s progress towards UHC
Identify relevant UHC resources within the Office of Health Systems and USAID
The presentation is part of the “UHC Toolkit” and accompanies Universal Health Coverage: An Annotated Bibliography, and Universal Health Coverage: Frequently Asked Questions.
Health Financing for UHC – two sides of the coinHFG Project
Presented at “Financial Protection and Improved Access to Health Care: Peer-to-Peer Learning Workshop Finding Solutions to Common Challenges” in Accra, Ghana, February 2016. To learn more, visit: https://www.hfgproject.org/ghana-uhc-workshop
Each year, the OHE sponsors a lecture that explores a timely issue in medicine or health economics. At the 22nd Annual Lecture, the issues and challenges of universal health care coverage in low- and middle-income countries were presented by Professor Anne Mills of the London School of Hygiene and Tropical Medicine.
The audio of this lecture now is available at http://news.ohe.org/2014/08/19/annual-lecture-2014-universal-health-coverage/
Universal Health Coverage (UHC) Day 12.12.14, NepalDeepak Karki
This presentation is made on the first ever Universal Health Coverage (UHC) Day 12.12.14 celebration in Nepal by Nepal Health Economics Association (NHEA).
Universal health coverage was established in the WHO constitution of 1948 declaring health a fundamental human right.The goal of universal health coverage is to ensure that all people obtain the health services they need without suffering financial hardship when paying for them.
Understanding the concept of Universal Health CoverageHFG Project
Presented during Day One of the 2016 Nigeria Health Care Financing Training Workshop. Presented by Dr. Elaine Baruwa. More: https://www.hfgproject.org/hcf-training-nigeria
Universal health coverage as a concept was born in 1883 when Germany introduced health coverage for achieving health status of its young population.India, is still attempting to find a way for providing appropriate, affordable and accessible health care to its population.
Policy Brief: What Steps Are Countries Taking To Implement Pro-Poor Universal...HFG Project
Universal health coverage (UHC)—ensuring that everyone has access to quality, affordable health services when needed—can be a vehicle for improved equity, health, financial well-being, and economic development. In its 2013 report, Global Health 2035: A World Converging within a Generation, the Commission on Investing in Health made the case that pro-poor pathways towards UHC, which target the poor from the outset, are the most efficient way to achieve both improved health outcomes and increased financial protection (FP). Countries worldwide are now embarking on health system changes to move closer to achieving UHC, often with a clear pro-poor intent.
Much has been written about what steps countries have taken and are currently taking to: (1) set and expand guaranteed services, (2) develop health financing systems to fund guaranteed services and ensure FP, (3) ensure high-quality service availability and delivery, (4) improve governance and management of the health sector, and (5) strengthen other aspects of health systems to move closer to UHC. As background for a meeting on UHC implementation, held at the Rockefeller Foundation’s Bellagio Center, Italy, from 7–9 July 2015, we reviewed this body of literature, and conducted interviews with global UHC implementers and researchers. In this short policy brief, we synthesize the key messages from the literature and interviews.
Universal health coverage (UHC)—ensuring that everyone has access to quality, affordable health services when needed—can be a vehicle for improved equity, health, financial well-being, and economic development. In its 2013 report, Global Health 2035, the Commission on Investing in Health (CIH) made the case that progressive (“pro-poor”) pathways towards UHC, which target the poor from the outset, are the most efficient way to achieve both improved health outcomes and increased financial protection (FP). Countries worldwide are now embarking on health system changes to move closer to achieving UHC, often with a clear pro-poor intent. While they can draw on guidance related to the technical aspects of UHC (the “what” of UHC), such as on service package design, there is less information on the “how” of UHC—that is, on how to maximize the chances of successful implementation.
Motivated by a shared interest in helping to close this information gap, a diverse international group of 21 practitioners and academics, including ministry of health officials and representatives of global health agencies and foundations, convened at The Rockefeller Foundation’s Bellagio Center for a three-day workshop from July 7–9, 2015. The participants shared their experiences of implementing UHC and discussed the limited evidence on how to implement UHC, focusing on a set of seven key “how” questions from across five domains of UHC.
Implementing Pro-Poor Universal Health CoverageHFG Project
From The Lancet Global Health: Countries worldwide are embarking on health system reforms that move them closer to UHC, in many cases with a clear pro-poor focus. Along the way, there is a wealth of guidance on the technical aspects of UHC, such as designing health service packages and developing health financing systems. However, there is very little practical guidance on how to implement these policies.
Motivated by a shared interest in helping to close this information gap, a diverse international group of 21 practitioners and academics, including ministry of health officials and representatives of global health agencies and foundations, convened at The Rockefeller Foundation’s Bellagio Center for a three-day workshop from July 7–9, 2015.
The participants shared their experiences of implementing UHC and discussed the limited evidence on how to implement UHC, focusing on a set of seven key “how” questions from across five domains of UHC.
Universal Health Coverage and Health Insurance - IndiaDr Chetan C P
Presentation is a case about cutting the risk fragmentation and having a universal pool for Health Insurance as one of the tools for achieving UHC in India.
INDIA : TOWARDS UNIVERSAL HEALTH COVERAGEDevesh Shukla
Challenges of Universal Health provision
Urban – Rural Divide Statistics
Current state of Healthcare in India
Change in consumer mindset
Milestones in Independent India
Way Forward in Health care
This presentation discusses IHME's research in public financing of health in developing countries, including study design, findings, study limitations, and recommendations for governments and future research.
For more information please visit www.healthmetricsandevaluation.org
Health access for all Thailand’s.The Thai citizens gain universal access to essential health services at zero cost, and reap significant benefits as babies get healthier, workers increase productivity, and households reduce financial risk.
Japan has made numerous achievements in health most notably the world’s highest life-expectancy in the past two decades, since its founding Universal Health Insurance System in 1961. However, ageing population with low-fertility rates, stagnating economy, increasing burden of NCDs and growing use of expensive technologies pose the critical challenges in service delivery and financial stability in health. Japan HiT reports current health system reforms undertaken and also recent discussion on paradigm shift to the new system as proposed in Japan Vision: Health Care 2035.
Looking at implementation: how useful is realist evaluation?valéry ridde
Presentation by Emilie Robert (McGill University).
Global Health Workshop: Methods For Implementation Science in Global Health.
http://www.equitesante.org/implementation-science-methods-in-global-health/
Understanding the concept of Universal Health CoverageHFG Project
Presented during Day One of the 2016 Nigeria Health Care Financing Training Workshop. Presented by Dr. Elaine Baruwa. More: https://www.hfgproject.org/hcf-training-nigeria
Universal health coverage as a concept was born in 1883 when Germany introduced health coverage for achieving health status of its young population.India, is still attempting to find a way for providing appropriate, affordable and accessible health care to its population.
Policy Brief: What Steps Are Countries Taking To Implement Pro-Poor Universal...HFG Project
Universal health coverage (UHC)—ensuring that everyone has access to quality, affordable health services when needed—can be a vehicle for improved equity, health, financial well-being, and economic development. In its 2013 report, Global Health 2035: A World Converging within a Generation, the Commission on Investing in Health made the case that pro-poor pathways towards UHC, which target the poor from the outset, are the most efficient way to achieve both improved health outcomes and increased financial protection (FP). Countries worldwide are now embarking on health system changes to move closer to achieving UHC, often with a clear pro-poor intent.
Much has been written about what steps countries have taken and are currently taking to: (1) set and expand guaranteed services, (2) develop health financing systems to fund guaranteed services and ensure FP, (3) ensure high-quality service availability and delivery, (4) improve governance and management of the health sector, and (5) strengthen other aspects of health systems to move closer to UHC. As background for a meeting on UHC implementation, held at the Rockefeller Foundation’s Bellagio Center, Italy, from 7–9 July 2015, we reviewed this body of literature, and conducted interviews with global UHC implementers and researchers. In this short policy brief, we synthesize the key messages from the literature and interviews.
Universal health coverage (UHC)—ensuring that everyone has access to quality, affordable health services when needed—can be a vehicle for improved equity, health, financial well-being, and economic development. In its 2013 report, Global Health 2035, the Commission on Investing in Health (CIH) made the case that progressive (“pro-poor”) pathways towards UHC, which target the poor from the outset, are the most efficient way to achieve both improved health outcomes and increased financial protection (FP). Countries worldwide are now embarking on health system changes to move closer to achieving UHC, often with a clear pro-poor intent. While they can draw on guidance related to the technical aspects of UHC (the “what” of UHC), such as on service package design, there is less information on the “how” of UHC—that is, on how to maximize the chances of successful implementation.
Motivated by a shared interest in helping to close this information gap, a diverse international group of 21 practitioners and academics, including ministry of health officials and representatives of global health agencies and foundations, convened at The Rockefeller Foundation’s Bellagio Center for a three-day workshop from July 7–9, 2015. The participants shared their experiences of implementing UHC and discussed the limited evidence on how to implement UHC, focusing on a set of seven key “how” questions from across five domains of UHC.
Implementing Pro-Poor Universal Health CoverageHFG Project
From The Lancet Global Health: Countries worldwide are embarking on health system reforms that move them closer to UHC, in many cases with a clear pro-poor focus. Along the way, there is a wealth of guidance on the technical aspects of UHC, such as designing health service packages and developing health financing systems. However, there is very little practical guidance on how to implement these policies.
Motivated by a shared interest in helping to close this information gap, a diverse international group of 21 practitioners and academics, including ministry of health officials and representatives of global health agencies and foundations, convened at The Rockefeller Foundation’s Bellagio Center for a three-day workshop from July 7–9, 2015.
The participants shared their experiences of implementing UHC and discussed the limited evidence on how to implement UHC, focusing on a set of seven key “how” questions from across five domains of UHC.
Universal Health Coverage and Health Insurance - IndiaDr Chetan C P
Presentation is a case about cutting the risk fragmentation and having a universal pool for Health Insurance as one of the tools for achieving UHC in India.
INDIA : TOWARDS UNIVERSAL HEALTH COVERAGEDevesh Shukla
Challenges of Universal Health provision
Urban – Rural Divide Statistics
Current state of Healthcare in India
Change in consumer mindset
Milestones in Independent India
Way Forward in Health care
This presentation discusses IHME's research in public financing of health in developing countries, including study design, findings, study limitations, and recommendations for governments and future research.
For more information please visit www.healthmetricsandevaluation.org
Health access for all Thailand’s.The Thai citizens gain universal access to essential health services at zero cost, and reap significant benefits as babies get healthier, workers increase productivity, and households reduce financial risk.
Japan has made numerous achievements in health most notably the world’s highest life-expectancy in the past two decades, since its founding Universal Health Insurance System in 1961. However, ageing population with low-fertility rates, stagnating economy, increasing burden of NCDs and growing use of expensive technologies pose the critical challenges in service delivery and financial stability in health. Japan HiT reports current health system reforms undertaken and also recent discussion on paradigm shift to the new system as proposed in Japan Vision: Health Care 2035.
Looking at implementation: how useful is realist evaluation?valéry ridde
Presentation by Emilie Robert (McGill University).
Global Health Workshop: Methods For Implementation Science in Global Health.
http://www.equitesante.org/implementation-science-methods-in-global-health/
Health Economics In Clinical Trials - Pubricapubrica101
Pubrica specializes in Health Economics in Clinical Trials, offering comprehensive support to ensure the economic aspects of your trial are effectively managed. From cost-effectiveness analysis to budgeting and reimbursement strategies, we help you optimize the economic outcomes of your trial. With Pubrica's expertise, you can navigate the complex landscape of health economics in clinical trials with confidence.
For more information, please refer to our service- https://pubrica.com/blog/research/health-economics-in-clinical-trials/ & Order now - https://pubrica.com/order-now/
Contact Our UK Medical Author’s;
Our email id – sales@pubrica.com
Contact No. +91 9884350006
Policy Implications of Healthcare Associated InfectionsAlbert Domingo
On February 19, 2014 at the Ateneo School of Medicine and Public Health in Pasig City, Dr. Albert Domingo presented an introduction to the economic impact of healthcare associated infections (HAIs) as well as related concepts in health policy and management. The speaker discussed common approaches taken to ascertain the economic impact of HAIs, followed by factors/considerations in Philippine health policy and management that must be understood and adjusted in order to minimize HAIs.
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...Office of Health Economics
These slides were presented by Professor Adrian Towse at the 9th World Congress of the International Health Economics Association in July 2013. The presentation examined how the development of health care systems affect the evolution of the use of health technology assessment. Three countries provide case studies: Brazil, China and Taiwan.
Health system strengthening evidence review – A summary of the 2021 updateReBUILD for Resilience
A presentation given by Professor Sophie Witter to the UK government's Foreign, Commonwealth & Development Office. This summarises a 2021 review of a health systems strengthening evidence review originally undertaken for the office in 2019.
Getting evidence from economic evaluation into healthcare practicecheweb1
Seminar:Understanding the underutilisation of evidence from economic evaluations in healthcare: a mixed methods design. Speaker: Gregory Merlo, Australian Centre for Health Services Innovation (AusHSI), Queensland University of Technology, Brisbane, Australia.
This presentation was given by our Chief Executive, Dr Jennifer Dixon, to the International Improvement Science and Research Symposium at the 2014 International Forum on Quality and Safety in Healthcare.
Does increasing fiscal space effect government funding for health?resyst
This presentation was given at the Health Financing and Governance Knowledge Synthesis Workshop held on 22-23 March in Abuja, Nigeria.
It presents findings from a RESYST study that sought to examine how Lagos state, Nigeria succeeded in increasing her tax revenue and effect government fiscal space for healthcare in the State.
This presentation was given at the 'Health Financing and Governance Knowledge Synthesis Workshop' held on 22-23 March in Abuja, Nigeria.
The presentation includes:
a definition of purchasing and a summary of three key purchasing functions;
an overview of the RESYST-APO purchasing study;
analysis of strategic purchasing within the Formal Sector social health insurance programme (FSSHIP) and Government Budget (GTR) in Nigeria;
Nature and effects of multiple funding flows to public healthcare facilities:...resyst
This presentation was given at the 'Health Financing and Governance Knowledge Synthesis Workshop' held on 22-23 March in Abuja, Nigeria.
It includes findings from a strand of RESYST's financing research which aims to examine how healthcare providers respond to multiple funding flows and the implications of such flows for achieving the health systems goals of equity, efficiency and quality.
The following resource was developed by RESYST for a research uptake and digital communications workshop held in Bangkok, Thailand.
In this resource:
- What is social media?
- Uses for social media in research uptake
- Online global health movements
- RESYST on social media
- How to get the most from twitter
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
The following resource was developed by RESYST for a research uptake and digital communications workshop held in Bangkok, Thailand.
In this resource:
- Benefits of using photos in online content
- Different types of photo
- How to use images effectively (good practice)
- Copyright, consent and creative commons
- Pablo: how to add text over images
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
The following resource was developed by RESYST for a research uptake workshop held in Kilifi, Kenya.
In this resource:
- Introduce data visualisation and demonstrate its value for research uptake and communications
- Compare different types of chart
- Share design tips for a visualisation
- Explore online data visualisation tools
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
The following resource was developed by RESYST for a research uptake and digital communications workshop held in Bangkok, Thailand.
In this resource:
- Understand how users read on the web
- Basic principles of writing for the web
- Review different types of written web content including blogs
- Blog writing structure
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
The following resource was developed by RESYST for a research uptake workshop held in Kilifi, Kenya.
In this resource:
- Learn how to develop key messages
- Introduce policy briefs: what, who and why?
- Explore what makes a good policy brief
- Plan a policy brief: audience, messages, problem, recommendations
- Write the outline of a policy brief
- Consider what format and design to use
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
The following resource was developed by RESYST for a research uptake workshop held in Kilifi, Kenya.
In this resource:
- Understand the importance of strategic planning for research uptake
- Familiarise key aspects of a research uptake strategy
- Develop research uptake objectives for your research group, project, hub or an event
- Identify key stakeholders using stakeholder analysis techniques
- Review communications channels, outputs and activities
- Explore indicators and tools for monitoring and evaluation
- Key questions to consider in a research uptake strategy
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
The following resource was developed by RESYST for a research uptake and digital communications workshop held in Bangkok, Thailand.
In this resource:
- Understand the importance of strategic planning for research uptake and digital communications
- Develop digital communications objectives for your research group, project or organisation
- Identify key stakeholders using stakeholder analysis techniques
- Review digital communications content, platforms and tools
- Explore indicators and tools for monitoring and evaluation
- Develop key messages from a journal article
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Researching Purchasing to achieve the promise of Universal Health Coverage
1. RESEARCHING PURCHASING TO
ACHIEVE THE PROMISE OF UNIVERSAL
HEALTH COVERAGE
Kara Hanson
Professor of Health System Economics
Department of Global Health and Development
2. OUTLINE
The UHC challenge
Strategic purchasing as the bridge to effective health coverage
Researching purchasing – economic theory-driven, case studies in
multiple country settings
3. THE CHALLENGE OF UNIVERSAL
HEALTH COVERAGE
• Universal health coverage means that everyone has access to quality
health services that they need without risking financial hardship
from paying for them
• Subject of many international and national plans and targets:
– UN General Assembly Resolution A/67/L.36: “Recognises the responsibility of
national governments to urgently and significantly scale up efforts to accelerate
the transition towards universal access to affordable and high quality health
services” (December 2012)
– Plethora of country plans, roadmaps, strategies, ….
5. “COVERAGE WITHOUT FINANCIAL
PROTECTION”
• Philippines, Indonesia, Vietnam – have all seen increases in
population coverage but no decrease in out-of-pocket payments
Coverage
OOP share
1030507090
1995 1998 2001 2004 2007 2010
Year
Source: WHO
Philippines
Coverage
OOP share
1030507090
Percent(%)
1995 1998 2001 2004 2007 2010
Year
Source: WHO
Vietnam
OOP share of total health spending
Coverage
102030405060
Percent(%)
1995 1998 2001 2004 2007 2010
Year
Outpatient
In
0.02.04.06.08.1.12.14.16
Percent(%)
1995 1998 2001 2004
Year
Outpatient and inpatient utili
Source: WHO; SUSENAS
Indonesia
Source: Presentations by A. Tandon, World Bank, at IHEA, Sydney, July 2013
6. WHAT MIGHT BE THE CAUSES?
• Incomplete coverage –
– Benefit package doesn’t meet perceived needs
– Unlimited co-payments/”balance billing”
• Insurance-induced utilization (with incomplete coverage)
• Weak referral system
• Perverse incentives to providers (eg. FFS, pharmaceutical revenue
maximization)
• High use of “out-of-plan” providers (private sector)
8. SOURCES OF HEALTH FINANCING
2010 (Source: WHO NHA)
1 6
23
4038
34
32
25
46
52
33 14
19
14
5 3 3
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Low Lower-middle Upper-midde High
Stacked bar chart by financing agents, 2010
Social health insurance Territorial government OOP Private prepaid Other private
9. POOLING
Accumulating prepaid health care revenues on behalf of a
population, with a particular emphasis on the population
coverage and composition of groups which are covered by a
specific pool
11. PURCHASING
• “Strategic purchasing aims to increase health systems’
performance through effective allocation of financial
resources to providers, which involves three sets of
explicit decisions:
– Which interventions should be purchased in response to
population needs and wishes, taking into account national
health priorities and evidence on cost-effectiveness;
– How they should be purchased, including contractual
mechanisms and payment systems; and
– From whom, in light of relative levels of quality and
efficiency of providers.” (Figueras et al. 2005)
12. SPECIFICATION OF THE SERVICE
ENTITLEMENT
• List what is excluded or what is included?
• Guarantee ‘basic’ package?
• Interventions selected based on criteria of cost-
effectiveness or financial protection?
• Comprehensive package or hospital care only?
• How to involve users in the setting of the package?
13. CONTRACTING AND PROVIDER
PAYMENT
Key difference between passive purchasing and strategic
purchasing
Specification of “contracts”
Provider payment mechanisms?
Pay for performance?
What information systems needed for monitoring?
How to build in support for quality improvement?
14. SELECTING PROVIDERS AND
ORGANISING ACCESS
• Limit to public providers only or use as a tool for involving the private
sector through contracts?
• Can provider selection be used to improve quality (eg. Accreditation)?
• Limited list of eligible providers (e.g. through accreditation scheme)
or all?
• Rules/limits on access to private providers?
• Patient incentives to encourage care at most appropriate level (e.g.
bypass fees)?
• Primary care gatekeeper role to limit access to higher levels of care?
• Make primary care a budget holder for referral care?
17. • Nature of the questions – exploratory/explanatory (“Why/How”) as well as
normative/evaluative (“What works/What is the best way to ….”)
• Study design dictated by the type of question
• Value of case study designs to link theory with process and outcomes
• Approaches to achieving methodological rigour with case study research
– Select cases carefully to offer insights
– Gather rich and deep information on contextual features relevant to each case
– Adopt an explanatory rather than a descriptive focus
– Consider multiple cases and conduct cross-case comparisons
– Use relevant theory to guide inquiry
» Walt, Shiffman et al. “Doing” health policy analysis…. Health Policy
and Planning 2008
CHARACTERISTICS OF HEALTH
POLICY AND SYSTEMS RESEARCH
18. MULTI-COUNTRY STUDY OF
PURCHASING ARRANGEMENTS:
• Describe the current purchasing mechanisms in participating countries
• Illustrate each of the selected purchasing mechanisms using a framework
of three core principal-agent relationships
• Critically assess the existing purchasing performance by examining what
actually occurs in current purchasing practices, focusing on the
behaviour/actions undertaken by the purchasers (actual practice), and
compare this with what purchasers would be expected to do under a
strategic purchasing mechanism (ideal practice)
• Identify factors that enable or hinder effective purchasing
• Draw lessons and make policy recommendations to promote effective
purchasing arrangements for universal coverage.
19. THEORETICAL FRAMEWORK
• Principal agent theory (Arrow 1985; Milgrom and Roberts 1992)
– How incentives, information, resources, decision-making, delivery mechanisms
and accountability work to structure the relationship between principal and
agent to achieve desired outcomes
21. METHODS
- Case study methodology
- Purchasing mechanism is the “case”
- Mixed methods – document review, key informant interviews,
secondary data analysis
- Theory-informed evaluation/assessment: Are the institutions
(resources, incentives, information, decision-making, delivery
mechanisms and accountability) in place to achieve the objectives of
strategic purchasing in a principal/agent framework
- Qualitative methods of analysis: Deductive analysis (based on
framework) complemented by inductive analysis + cross-case
comparison (within and between countries)
22. Health Economics and Systems
Analysis Group, LSHTM
Health Economics Unit,
University of Cape Town
International Health
Policy Programme,
Thailand
KEMRI-WT Programme
AMREF, Kenya
Health Policy Research Group,
University of Nigeria
Health Strategy &
Policy Institute, Vietnam
Ifakara Health Institute,
Tanzania
Indian Institute of
Technology, Madras
STUDY COUNTRIES
Peking University,
China
Universitas
Gadjah Mada,
Indonesia
Philippines
23. PURCHASING MECHANISMS BEING
EXAMINED IN STUDY COUNTRIES
General tax funded
service
Social Health
Insurance
Private / voluntary
insurance
China √ (NCMS)
India (Tamil Nadu) √ √
Indonesia √ √√
Kenya √ √
Nigeria √ √
Philippines √
South Africa √ √
Tanzania √ √ √
Thailand √ √ (CSMBS)
Vietnam √ √
24. CONCLUSIONS
• Achieving UHC requires action on all dimensions of the “cube”
• Purchasing creates the link between pooled funds and effective
services; but little research which takes a comprehensive, “strategic”
perspective on design of purchasing in health systems
• Theory-driven case studies are a valuable research methodology in
health economics and health system research
25. ACKNOWLEDGEMENTS
UK Department for International Development
Asia-Pacific Observatory on Health Systems and Policies
Collaborators – especially Ayako Honda, study coordinator, and Di
McIntyre (University of Cape Town)
Country research teams
Editor's Notes
Privilege to be involved in two efforts over past years to reflect on nature of HPSR, and how to ensure that it is rigorous in its methods; partly a response to a perception that HPSR being held to narrow standards of clinical research – esp wrt evaluation of interventions; but also that methods of qualitative research are poorly understood by public health journals.
Very luck this week to have 2 members of our Consortium Advisory Committee – Kate Hawkins and Sally Theobald, to join in discussions.